TP53 and gestational diabetes: For instance, circ-DNMT1 promotes GDM progression by inducing p53 expression and activating the JAK/STAT pathway, while DUSP9 exacerbates insulin resistance and metabolic dysfunction by inhibiting the IRS1/PI3K/AKT pathway [49,50].